Valvular Atrial Fibrillation (VAF) is a distinct category of atrial fibrillation that manifests in individuals with significant heart valve disorders. The abnormal electrical signals within the atria, or upper chambers of the heart, lead to irregular and often accelerated heartbeats. The link between VAF and valvular heart diseases, such as mitral stenosis or the presence of a mechanical heart valve, underscores the complexity of this condition. The management of VAF requires a nuanced approach, taking into account both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals navigate treatment strategies based on factors like the severity of the valve disease, the overall health status of the patient, and individual considerations unique to each case. Striking a balance between addressing atrial fibrillation and managing valvular issues is crucial for effective care.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Therapeutic pneumoperitoneum mimicking inferior myocardial infarction and right ventricular aneurysm: A case report
Abhinav Prithvi Venkata Sesha Kanigicherla, University Hospital Coventry and Warwickshire NHS Trust, United Kingdom
Title : Multisystem IgG4-related disease with cardiac involvement mimicking cardiac sarcoidosis: a diagnostic challenge background
Natasha Manuelpillai, Salisbury District Hospital- NHS, United Kingdom
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation